Transgenic Animal Market to be dominated by Growing Consumption of Animal-derived Protein and Dairy Products through 2027
Growing consumption of
animal-derived protein and rise in R&D activities to drive the transgenic
animal market in the forecast period, 2023-2027.
According to TechSci Research
report, “Transgenic Animal Market - Global Industry Size, Share,
Trends, Opportunity, and Forecast, 2017-2027”, the global transgenic
animal market is anticipated to grow at a significant rate in the forecast
period, 2023-2027. The increase in consumption of animal-derived protein and
dairy products and rise in R&D activities are the primary factors driving
the demand for the global transgenic animal market. Growing technological advancement,
wide application in various areas, and heavy investments in R&D activities are
expected to influence the market demand. Also, the rise in population and rapid
urbanization worldwide are also a key factor for driving the growth of the transgenic
animal market, globally.
However Strict rules of government and the policies so put
forward by the FDA act as a restraining factor affecting transgenic animals
market growth.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Global
Transgenic Animal Market"
The global transgenic
animal market is segmented product, PCR, technique, application, model
organism, end user and company.
Based on
product, the market is divided into gene gun, PCR, microinjections, and others.
The PCR segment is sub-segmented into real-time PCR, digital PCR systems, and
others. The PCR segment is expected to hold the largest market share as it is the
most effective method for detecting minor degenerated nucleic acids and
determining their sequence. Also, it only uses a DNA fragment to detect
species.
Based on
technique, the market is segmented into DNA microinjection, embryonic stem
cell-mediated gene transfer, retrovirus-mediated gene transfer, and others. The DNA microinjection is forecasted to hold
the largest market share, owing to the potential applications of these
techniques in the correction of genetic defects, its simplicity and efficiency.
Based on
application, the market is segmented into recombinant human proteins,
monoclonal antibodies, xenotransplantation, and others. The monoclonal
antibodies are predicted to hold a significant market share as
they aims to enhance or provoke one's immune system to produce antibodies that
are efficacious in fighting the foreign antigen.
Based on model
organisms, the market is segmented into mice, rabbit, cow, and others. The mice
segment is projected to grow the market in upcoming years, owing to their
genetic similarity to humans, and increasing use in the study of human
diseases.
Based on end
user, the market is segmented into biotechnology & pharmaceutical
companies, academic & research organizations, and others. The academic
& research organizations are augmenting the market growth due to the
increasing demand for the development of novel drugs and specialized
medications, and growing R&D & clinical trials across the globe.
Major
operating companies operating in global Transgenic Animal market are:
·
Market
Players Merck & Co., Inc.
·
C.H.
Boehringer Sohn Ko. KG
·
Randox
Laboratories Limited, Zoetis, Inc.
·
Virbac
SA, Elanco Animal Health Inc.
·
Biogénesis
Bagó SA
·
Santa
Cruz Biotechnology, Inc
·
Idexx
Laboratories, Inc.
·
Innovative
Diagnostics (IDVet)
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“Asia-Pacific region
dominates the market in 2021 and is expected to maintain its dominance in the
coming years due to increase in R&D initiatives and enhanced investments
from governments for overall R&D of drugs. Also, availability of advanced healthcare systems,
and increase in population contribute to propel the global transgenic
animal market growth till 2027” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Transgenic Animal Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented
By Product (Gene Gun, PCR, Microinjections, Others), By PCR (Real-Time PCR,
Digital PCR Systems, Others), By Technique (DNA Microinjection, Embryonic Stem
Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others), By
Application (Recombinant Human Proteins, Monoclonal Antibodies,
Xenotransplantation, Others), By Model Organisms (Mice, Rabbit, Cow, Others),
By End User (Biotechnology & Pharmaceutical Companies, Academic &
Research Organizations, Others), By Company, and By Region”, has evaluated the future
growth potential of transgenic animal and provides statistics & information
on market size, structure, and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in global
transgenic animal market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com